The dependence on existing cell-lines in drug development pipelines suffers from a lack of biological fidelity with the human disease, which is unique and complex. Use of 3D models with primary, genetically-defined cells allows for better
Download the presentation and you'll learn:
- Key Cellaria cell models and media currently available for your use
- The impact of the ORGANDOT™ format for assessing the effect of chemotherapeutic agents using primary cell models
- How to integrate primary cell, 3D cell models with downstream applications to generate complete drug sensitivity data packages, with established expected response to standard chemotherapeutics
Download Now
Copyright © 2024 BioIVT. All Rights Reserved. Contact Us.